Evaluation of toxicities related to novel therapy in clinical trials for women with gynecologic cancer
Author:
Affiliation:
1. Princess Margaret Cancer Centre University Health Network Toronto Ontario Canada
2. Cancer Therapy Evaluation Program National Cancer Institute Bethesda Maryland
Funder
Australian Government Research Training Program
Publisher
Wiley
Subject
Cancer Research,Oncology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32783
Reference22 articles.
1. Moving From Mutation to Actionability
2. Trends in the Risks and Benefits to Patients With Cancer Participating in Phase 1 Clinical Trials
3. Risks and Benefits of Phase 1 Oncology Trials, 1991 through 2002
4. American Society of Clinical Oncology Policy Statement Update: The Critical Role of Phase I Trials in Cancer Research and Treatment
5. Predictive Value of Phase I Trials for Safety in Later Trials and Final Approved Dose: Analysis of 61 Approved Cancer Drugs
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. High grade adverse event reporting and enrolment in gynecologic oncology clinical trials;Gynecologic Oncology;2024-06
2. Managing Adverse Effects Associated With Poly (ADP-ribose) Polymerase Inhibitors in Ovarian Cancer: A Synthesis of Clinical Trial and Real-World Data;American Society of Clinical Oncology Educational Book;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3